Trade ENSC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ensysce Biosciences, Inc. (ENSC) is trading at US$0.39, down 1.50% today as of Aug 28, 11:36 EDT. The company has a market capitalisation of US$7.26M. Over the past 52 weeks, ENSC has traded between US$0.23 and US$2.75. On Syfe you can trade ENSC with $0 commission and add it to your watchlist.
| Previous close | US$0.40 |
|---|---|
| Market cap | US$7.26M |
| 52-week range | US$0.23 – US$2.75 |
| Volume | 560.3K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ensysce Biosciences, Inc.
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Year: 2021
Ensysce Biosciences Enrolls First Patient in Final Phase of Oral Overdose Study
Jun 26, 12:47 PM · MT Newswires
Ensysce Biosciences Files for Sale of 1.3 Million Shares
Jun 4, 9:02 PM · MT Newswires
Ensysce Biosciences, Inc. (ENSC) stock is trading at US$0.39, -1.50% from the previous close of US$0.40.
The market cap for Ensysce Biosciences, Inc. (ENSC) stock is approximately US$7.26M.
The 52-week high for Ensysce Biosciences, Inc. (ENSC) stock is US$2.75.
The 52-week low for Ensysce Biosciences, Inc. (ENSC) stock is US$0.23.
Ensysce Biosciences, Inc. (ENSC) does not currently pay a dividend.
Stay on top of ENSC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
